U.S. flag

An official website of the United States government

NM_000520.6(HEXA):c.397del (p.Trp133fs) AND Tay-Sachs disease

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jun 13, 2019
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001216462.5

Allele description [Variation Report for NM_000520.6(HEXA):c.397del (p.Trp133fs)]

NM_000520.6(HEXA):c.397del (p.Trp133fs)

Gene:
HEXA:hexosaminidase subunit alpha [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
15q23
Genomic location:
Preferred name:
NM_000520.6(HEXA):c.397del (p.Trp133fs)
HGVS:
  • NC_000015.10:g.72355574del
  • NG_009017.2:g.25606del
  • NM_000520.6:c.397delMANE SELECT
  • NM_000520.6:c.397del
  • NM_001318825.2:c.430del
  • NP_000511.2:p.Trp133fs
  • NP_001305754.1:p.Trp144fs
  • NC_000015.9:g.72647915del
  • NM_000520.4:c.397del
  • NR_134869.3:n.439del
Protein change:
W133fs
Links:
dbSNP: rs2088765656
NCBI 1000 Genomes Browser:
rs2088765656
Molecular consequence:
  • NM_000520.6:c.397del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001318825.2:c.430del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NR_134869.3:n.439del - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Tay-Sachs disease (TSD)
Synonyms:
GM2 gangliosidosis, type 1; HexA deficiency; Hexosaminidase alpha-subunit deficiency (variant B); See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0010100; MedGen: C0039373; Orphanet: 845; OMIM: 272800

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV001388260Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))		Pathogenic
(Jun 13, 2019) 		germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sequence of DNA flanking the exons of the HEXA gene, and identification of mutations in Tay-Sachs disease.

Triggs-Raine BL, Akerman BR, Clarke JT, Gravel RA.

Am J Hum Genet. 1991 Nov;49(5):1041-54.

PubMed [citation]
PMID:
1833974
PMCID:
PMC1683266

Ten novel mutations in the HEXA gene in non-Jewish Tay-Sachs patients.

Akli S, Chomel JC, Lacorte JM, Bachner L, Kahn A, Poenaru L.

Hum Mol Genet. 1993 Jan;2(1):61-7. Erratum in: Hum Mol Genet 1993 Apr;2(4):496.

PubMed [citation]
PMID:
8490625
See all PubMed Citations (3)

Details of each submission

From Invitae, SCV001388260.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

This sequence change creates a premature translational stop signal (p.Trp133Glyfs*66) in the HEXA gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with HEXA-related conditions. Loss-of-function variants in HEXA are known to be pathogenic (PMID: 1833974, 8490625). For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 20, 2024